INDSWIFT LABORATORIES
|
The Current P/S Ratio of INDSWIFT LABORATORIES is 0.49.
Share Price | ₹105.7 | May 27,2024 |
Market Cap | ₹624.7 Cr | |
Sales-TTM | ₹1,280.9 Cr | TTM-Consolidated Results |
Price/Sales | 0.49x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of INDSWIFT LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹624.7 Cr] as on May 27,2024
(/) Sales [ ₹1,280.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 0.49x ]
Thus, for INDSWIFT LABORATORIES , the investors are currently willing to pay '0.49 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of INDSWIFT LABORATORIES !
The chart below summarizes the trend in P/S Ratio of INDSWIFT LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of INDSWIFT LABORATORIES
PS Ratio Performance Analysis for INDSWIFT LABORATORIES
- INDSWIFT LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.31x.
- INDSWIFT LABORATORIES 's operated at median p/e ratio of 0.27x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDSWIFT LABORATORIES 's p/e ratio peaked in Mar2021 at 0.48x.
- INDSWIFT LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.16x.
How does INDSWIFT LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
INDSWIFT LABORATORIES | 1,280.9 | 0.49 | 624.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 48,496.9 | 7.26 | 351,910.0 |
CIPLA LTD | 25,774.1 | 4.63 | 119,369.0 |
DR REDDYS LABORATORIES LTD | 28,011.1 | 3.50 | 98,161.7 |
ZYDUS LIFESCIENCES LTD | 19,547.4 | 5.45 | 106,515.0 |
DIVIS LABORATORIES LTD | 7,845.0 | 14.40 | 112,930.0 |
MANKIND PHARMA LTD | 10,334.8 | 8.20 | 84,734.3 |
TORRENT PHARMACEUTICALS LTD | 10,728.0 | 8.37 | 89,825.1 |
LUPIN LTD | 20,010.8 | 3.68 | 73,653.0 |
AUROBINDO PHARMA LTD | 29,001.9 | 2.42 | 70,057.8 |
ABBOTT INDIA LTD | 5,848.9 | 9.53 | 55,769.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs INDSWIFT LABORATORIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 0.49x |
Max industry PS | 14.40x |
Median industry PS | 5.45x |
Average industry PS | 6.18x |
You may also like the below Video Courses